Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Diabet Med ; 22(10): 1440-3, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16176209

RESUMO

BACKGROUND: Atypical antipsychotics have become the mainstay of management of schizophrenia and other psychotic disorders due to low risk of extrapyramidal symptoms. However, postmarketing data has reported atypical antipsychotic agents being associated with hyperglycaemia and diabetic ketoacidosis (DKA). We believe this to be the first published report of hyperglycaemia and DKA with the newest atypical antipsychotic agent, aripiprazole. CASE REPORT: A 34-year-old African-American female with schizophrenia presented to the emergency department with nausea, vomiting, and malaise for 3-4 days shortly after initiation of aripiprazole therapy. Initial laboratory results revealed significant hyperglycaemia with metabolic acidosis. The patient received treatment for DKA with an intravenous insulin infusion and fluid replacement. Isophane insulin suspension (NPH insulin) was begun immediately following the insulin drip and continued upon discharge from the hospital. Outpatient follow-up information was not available. CONCLUSION: To our knowledge, this is the first case report of aripiprazole associated with hyperglycaemia and DKA. This case is striking in that DKA occurred 4 days following initiation of aripiprazole and the patient had rapid resolution of symptoms and normalization of laboratory values upon discontinuation of aripiprazole. It is important that health-care providers monitor for hyperglycaemia when prescribing atypical antipsychotics including aripiprazole.


Assuntos
Antipsicóticos/efeitos adversos , Cetoacidose Diabética/induzido quimicamente , Piperazinas/efeitos adversos , Quinolonas/efeitos adversos , Esquizofrenia/tratamento farmacológico , Adulto , Aripiprazol , Cetoacidose Diabética/tratamento farmacológico , Feminino , Humanos , Infusões Intravenosas , Insulina/administração & dosagem , Insulina Isófana/administração & dosagem , Resultado do Tratamento
2.
Pharmacotherapy ; 21(11): 1364-7, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11714209

RESUMO

Prussian blue is a crystal lattice that exchanges potassium for cesium at the surface of the crystal. When given orally, it binds cesium that is secreted in the gut before it can be reabsorbed. Data suggest that in humans, Prussian blue can reduce cesium's half-life by approximately 43% and reduce total body burdens. Prussian blue is well tolerated at a dosage of 3 g/day with appropriate monitoring of serum potassium levels and observing for signs of constipation. Clinical data on the efficacy of Prussian blue in the management of radiocesium poisoning were evaluated. Articles published in English describing distribution and elimination of cesium in both humans and animals were reviewed, along with articles describing administration of Prussian blue in clinical toxicology.


Assuntos
Antídotos/uso terapêutico , Radioisótopos de Césio/intoxicação , Ferrocianetos/uso terapêutico , Animais , Antídotos/farmacocinética , Radioisótopos de Césio/farmacocinética , Ferrocianetos/farmacocinética , Humanos
4.
Ann Pharmacother ; 34(7-8): 843-7, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10928392

RESUMO

OBJECTIVE: To describe the influence of pharmacy faculty, residents, and students at a community hospital by documenting the number and types of interventions attributable to their involvement in patient-care activities. METHODS: Between September 1, 1997, and May 31, 1999, data were collected using a computerized documentation system to characterize the intervention type, significance, and value of services rendered by an education group composed of pharmacy faculty (n = 2), residents (n = 4), and students (n = 22). RESULTS: The number, nature, and outcome category for all interventions were documented using an existing computerized documentation system. The education group accounted for 13% (n = 2,873) of total clinical activities documented (n = 21,817). The most common activities reported were discharge counseling/education (31%), consultation by physicians and therapeutic recommendations (15%), and route conversion (6%). Interventions documented by the education group were classified as medium or high significance 50% of the time. Sixteen percent ($172,655) of the estimated cost avoidance documented by the pharmacy department was attributed to the education group. CONCLUSIONS: This study demonstrates that educational activities by pharmacy faculty, residents, and students have a positive influence on patient care in a community hospital.


Assuntos
Documentação , Educação em Farmácia , Equipe de Assistência ao Paciente/estatística & dados numéricos , Alabama , Redução de Custos , Atenção à Saúde , Educação de Pós-Graduação em Farmácia , Docentes , Hospitais Comunitários , Humanos , Internato não Médico , Prontuários Médicos , Estudantes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...